JP2024526234A5 - - Google Patents
Info
- Publication number
- JP2024526234A5 JP2024526234A5 JP2023580406A JP2023580406A JP2024526234A5 JP 2024526234 A5 JP2024526234 A5 JP 2024526234A5 JP 2023580406 A JP2023580406 A JP 2023580406A JP 2023580406 A JP2023580406 A JP 2023580406A JP 2024526234 A5 JP2024526234 A5 JP 2024526234A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleotides
- dsrna agent
- agent according
- myoc
- nucleotide sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163215804P | 2021-06-28 | 2021-06-28 | |
| US63/215,804 | 2021-06-28 | ||
| US202163287404P | 2021-12-08 | 2021-12-08 | |
| US63/287,404 | 2021-12-08 | ||
| US202263351033P | 2022-06-10 | 2022-06-10 | |
| US63/351,033 | 2022-06-10 | ||
| PCT/US2022/035266 WO2023278406A1 (en) | 2021-06-28 | 2022-06-28 | Compositions and methods for silencing myoc expression |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024526234A JP2024526234A (ja) | 2024-07-17 |
| JP2024526234A5 true JP2024526234A5 (https=) | 2025-07-09 |
Family
ID=84692959
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023580406A Pending JP2024526234A (ja) | 2021-06-28 | 2022-06-28 | Ｍｙｏｃ発現をサイレンシングするための組成物および方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240318175A1 (https=) |
| EP (1) | EP4363587A4 (https=) |
| JP (1) | JP2024526234A (https=) |
| KR (1) | KR20240026216A (https=) |
| AU (1) | AU2022301058A1 (https=) |
| CA (1) | CA3224868A1 (https=) |
| IL (1) | IL309230A (https=) |
| MX (1) | MX2023014976A (https=) |
| TW (1) | TW202317148A (https=) |
| WO (1) | WO2023278406A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20240117571A (ko) * | 2021-12-08 | 2024-08-01 | 리제너론 파마슈티칼스 인코포레이티드 | 돌연변이 마이오실린 질환 모델 및 이의 용도 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005117938A2 (en) * | 2004-04-13 | 2005-12-15 | Regents Of The University Of Minnesota | Methods of treating ocular conditions |
| EP2313505A2 (en) * | 2008-07-15 | 2011-04-27 | F. Hoffmann-La Roche AG | Compositions and methods for inhibiting expression of tgf-beta receptor genes |
| EP3540061A1 (en) * | 2014-04-02 | 2019-09-18 | Editas Medicine, Inc. | Crispr/cas-related methods and compositions for treating primary open angle glaucoma |
| SG11201702055PA (en) * | 2014-09-16 | 2017-04-27 | Genzyme Corp | Adeno-associated viral vectors for treating myocilin (myoc) glaucoma |
| PL4012035T3 (pl) * | 2014-09-16 | 2025-03-24 | Genzyme Corporation | Wektory wirusowe związane z adenowirusami do leczenia jaskry miocylinowej (myoc) |
| KR20230008729A (ko) * | 2020-04-06 | 2023-01-16 | 알닐람 파마슈티칼스 인코포레이티드 | Myoc 발현을 사일런싱하기 위한 조성물 및 방법 |
-
2022
- 2022-06-28 WO PCT/US2022/035266 patent/WO2023278406A1/en not_active Ceased
- 2022-06-28 MX MX2023014976A patent/MX2023014976A/es unknown
- 2022-06-28 KR KR1020247003233A patent/KR20240026216A/ko active Pending
- 2022-06-28 EP EP22834044.4A patent/EP4363587A4/en active Pending
- 2022-06-28 TW TW111124088A patent/TW202317148A/zh unknown
- 2022-06-28 IL IL309230A patent/IL309230A/en unknown
- 2022-06-28 AU AU2022301058A patent/AU2022301058A1/en active Pending
- 2022-06-28 US US18/572,486 patent/US20240318175A1/en active Pending
- 2022-06-28 JP JP2023580406A patent/JP2024526234A/ja active Pending
- 2022-06-28 CA CA3224868A patent/CA3224868A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Fattal et al. | Ocular delivery of nucleic acids: antisense oligonucleotides, aptamers and siRNA | |
| US5731294A (en) | Inhibition of neovasularization using VEGF-specific oligonucleotides | |
| JP5592892B2 (ja) | 眼障害の治療方法 | |
| US5661135A (en) | Human VEGF-specific oligonucleotides | |
| JP2022501057A5 (https=) | ||
| EP1141278B1 (en) | Therapeutic pde4d phosphodiesterase inhibitors | |
| US20190144865A1 (en) | Modified tgf-beta oligonucleotide for use in a method of preventing and/or treating an ophthalmic disease | |
| JP2024526234A5 (https=) | ||
| CN108026530B (zh) | siRNA及其在抑制NRARP基因表达的方法和组合物中的用途 | |
| US10570394B2 (en) | Double-stranded RNA compounds to CASP2 and uses thereof | |
| US20140323549A1 (en) | Methods and compositions for treating diseases, disorders or injury of the nervous system | |
| RU2653766C2 (ru) | КиРНК И ИХ ИСПОЛЬЗОВАНИЕ В СПОСОБАХ И КОМПОЗИЦИЯХ ДЛЯ ЛЕЧЕНИЯ И/ИЛИ ПРОФИЛАКТИКИ ГЛАЗНЫХ ЗАБОЛЕВАНИЙ | |
| TWI585205B (zh) | ＭicroＲＮＡ－３２８反股組合物與其醫療用途 | |
| JP2023514190A5 (https=) | ||
| JP2024522106A5 (https=) | ||
| JP2024538646A5 (https=) | ||
| IL295445A (en) | Preparations and methods for silencing vegf-a expression | |
| KR102421751B1 (ko) | 연결 조직 성장 인자를 표적으로 하는 RNAi 제제 및 이의 용도 | |
| WO2025167275A1 (zh) | 一种靶向视网膜色素上皮细胞的递送系统及其应用 | |
| WO2025153084A1 (zh) | 用于抑制胰岛素样生长因子1受体表达的rna抑制剂 | |
| KR20240016895A (ko) | 카텝신 s 발현억제를 통한 황반변성의 예방 및 치료 | |
| KR20250164214A (ko) | 아탁신-2(ATXN2)의 발현을 억제하기 위한 RNAi 제제, 이의 조성물, 및 사용 방법 | |
| CN116459270A (zh) | 一种药物组合物及其在制备防治眼部新生血管性疾病药物中的应用 |